//
Hang Quach
Sung-Soo Yoon
Kihyun Kim
Ji Hyun Lee
Chandramouli Nagarajan
Phoebe Joy Ho
Michael S.Y. Low
Wei-Han Huang
Raymond Wong
Nina Liao
ChingFeng Lin
Matthew Britland
Julia Li
Stella Chai
Jin Seok Kim
Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan Univ. Sch. of Med. Samsung Medical Center, Seoul, Korea, Republic of (South)
Sir YK Pao Centre for Cancer & Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, Hong Kong
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of (South)
University of Melbourne, St. Vincent's Hospital, Melbourne, Australia
Royal Prince Alfred Hospital and University of Sydney, Camperdown, Sydney, Australia
Seoul National University Hospital, Seoul, Korea, Republic of (South)
Monash Medical Centre, Melbourne, Australia
Department of Internal Medicine, Dong-A University College of Medicine, Busan, South Korea
Parexel International, Taipei, Taiwan
SingHealth Duke-NUS Blood Cancer Center and Singapore General Hospital, Singapore, Singapore
Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien City, Taiwan
Hong Kong
Republic of South Korea
Australia
Singapore
Taiwan
N/A
Oncology (ONC)
Multiple Myeloma
N/A
carfilzomib Intravenous
N/A
Single Arm
Prospective
Cohort
NA
N/A
N/A
N/A